Related Experiment Video
Updated: Jul 10, 2026

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
Uterine rupture and perinatal outcome
Katarina Widén Pettersson1, Charlotta Grunewald, Peter Thomassen
1Department of Obstetrics and Gynecology, Stockholm South General Hospital, Stockholm, Sweden.
Acta Obstetricia Et Gynecologica Scandinavica
|October 27, 2007
Summary
Uterine rupture is rare, occurring in 0.9/1000 deliveries, often in women with prior uterine scars. Newborns had a low risk of long-term neurological issues despite some initial complications.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Surgical Outcomes
Background:
- Investigating clinical aspects and perinatal outcomes of uterine rupture due to rising caesarean section (CS) rates.
- Retrospective analysis of 24,181 deliveries from 1999-2004 at Stockholm South General Hospital.
- Utilized ICD-codes 0710 and 0711, previous delivery records, and neonatal data.
Observation:
- Identified 22 cases of uterine rupture, with an incidence of 0.9 per 1,000 deliveries.
- Diagnosis confirmed via laparotomy in all cases.
- 19 out of 22 cases involved patients with a history of uterine scarring.
Findings:
- Uterine rupture occurred in 18 deliveries at term and one at 16 weeks gestation.
- One intrauterine fetal death was recorded.
- Of 20 live births, 9 had a 5-minute Apgar score ≤7; one neonate died within 3 days, and another experienced neurological sequelae.
Implications:
- A previous uterine scar is the primary risk factor for uterine rupture.
- The study highlights a relatively low risk of long-term post-asphyctic sequelae in newborns affected by uterine rupture.
- Emphasizes the importance of considering uterine scar history in managing deliveries.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Esophageal Perforation-II: Clinical Manifestations and Management
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
Esophageal Perforation-I: Introduction
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
